Advertisement

Immunologic Factors Related to Cognitive/Behavioral Dysfunctions in Aging

  • H. Lal
  • M. J. Forster
  • K. Nandy
Part of the Advances in Applied Neurological Sciences book series (NEUROLOGICAL, volume 2)

Abstract

The loss of synapses (Bondareff 1976, 1980), the disappearance of neurotransmitter binding sites (Finch 1982; Lal and Carroll 1979; Severson and Finch 1980), and the mortality of neurons themselves (Colon 1973; Vogel 1969; Johnson and Erner 1972) are conspicuous changes observed in the normally aging mammalian CNS, and they have long been recognized as possible immediate causes for senescence-related declines in the capacity for adaptive behavior of both humans and animals (Landfield 1983; Rapport and Karpiak 1978). Continued research will no doubt further clarify the nature of degenerative changes in the normally aging brain, their contributions to normal senescence-related behavioral changes, and their relevance to senescence-related neuropsychopathology in humans.

Keywords

Systemic Lupus Erythematosus Avoidance Response Senile Plaque Senile Dementia Immunologic Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baldinger A, Blumenthal HT (1982) Neuroimmunology of the aging brain. In: Platt D (ed) Geriatrics. Springer, Berlin Heidelberg New York, pp 283–299Google Scholar
  2. Bartus RT, Dean RL, Beer B (1980) Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics. Neurobiol Aging 1: 145–152CrossRefGoogle Scholar
  3. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the central gray matter of elderly subjects. Br J Psychiatry 144: 797–811CrossRefGoogle Scholar
  4. Bluestein HG, Woods VL (1982) Antineuronal antibodies in systemic lupus erythematosus. Arthritis Rheum 25: 773–778PubMedCrossRefGoogle Scholar
  5. Blumenthal HT (1976) Immunological aspects of the aging brain. In: Terry RD, Gershon S (eds) Neurobiology of aging, vol 3. Raven, New York, pp 313–334Google Scholar
  6. Blumenthal HT, Young D, Wozniak D, Finger S (1984) Effects of age, brain damage and stress on antibody binding to the brain. J Gerontol 39: 552–560PubMedGoogle Scholar
  7. Bondareff W (1976) Loss of synapses in the dentate gyrus of the senescent rat. Am J Anat 145: 129–136PubMedCrossRefGoogle Scholar
  8. Bondareff W (1980) Compensatory loss of axosomatic synapses in the dentate gyrus of the senescent rat. Mech Ageing Dev 12: 221–229PubMedCrossRefGoogle Scholar
  9. Buell SJ, Rudick RA (1983) Integrity of blood-brain barrier to peroxidase in senescent mice. Neurobiol Aging 4: 283–287PubMedCrossRefGoogle Scholar
  10. Burns EM, Kruckeberg TW, Gaetano PK (1981) Changes with age in cerebral capillary morphology. Neurobiol Aging 2: 285–291CrossRefGoogle Scholar
  11. Campbell BA, Spear NE (1972) Ontogeny of memory. Psychol Rev 79: 215–236PubMedCrossRefGoogle Scholar
  12. Campbell BA, Krauter EE, Wallace JE (1980) Animal models of aging: Sensory-motor and cognitive function in the aged rat. In: Stein (ed) The psychobiology of aging: problems and perspectives. Elsevier, Amsterdam, pp 201–226Google Scholar
  13. Carr RI, Shucard DW, Hoffman SA, Hoffman AW, Bardana EJ, Harbeck RJ (1978) Neuropsychiatrie involvement in systemic lupus erythematosus. In: Bergsma D, Goldstein AL (eds) Neurochemical and immunologic components in schizophrenia. Liss, New York, pp 209–235Google Scholar
  14. Chaffee J, Nassef M, Bobin S (1978) Cytotoxic autoantibody to the brain. In: Nandy K (ed) Senile dementia: A biomedical approach. Elsevier, Amsterdam, pp 61–72Google Scholar
  15. Colon EJ (1973) The cerebral cortex in presenile dementia: a qualitative analysis. Acta Neuropathol 23: 281–290PubMedCrossRefGoogle Scholar
  16. Dean RL, Scozzafava J, Goas JA, Regan B, Beer B, Bartus RT (1981) Age-related differences in behavior across the life span of the C57BL/6J mouse. Exp Aging Res 7: 427–451PubMedCrossRefGoogle Scholar
  17. Delespesse G, Guasset PH, Sarfati M, Dubi-Rucquoy M, Debisschop MJ, Van Haelst L (1980) Circulating immune complexes in old people and diabetics: Correlation with autoantibodies. Clin Exp Immunol 40:96–102PubMedGoogle Scholar
  18. Eisdorfer C, Cohen D, Buckley CE III (1978) Serum immunoglobulins and cognition in the impaired elderly. In: Katzman R, Terry R, Bick K (eds) Alzheimer’s disease—Senile dementia and related disorders. Raven, New York, pp 401–407 (Aging, vol. 7 )Google Scholar
  19. Feden G, Baldinger A, Miller-Soule D, Blumenthal HT (1979) An in vivo and in vitro study of an aging-related neuron cytoplasmic binding antibody in male Fischer rats. J Gerontol 34: 651–660PubMedGoogle Scholar
  20. Fernandes G, Yunis EJ, Smith J, Good RA (1971) Dietary influence on breeding behavior, hemolytic anemia, and longevity in NZB mice. Proc Soc Exp Biol Med 139: 1189–1196Google Scholar
  21. Fernandes GE, Yunis J, Good RA (1976) Influence of protein restriction in immune functions in NZB mice. J Immunol 116: 782–790PubMedGoogle Scholar
  22. Finch CE (1982) Rodent models for aging processes in the human brain. In: Corkin S, Davis KL, Growdon JH, Usdin E, Wurtman RJ (eds) Alzheimer’s disease: A report of progress in research. Raven, New York, pp 249–257 (Aging, vol 19 )Google Scholar
  23. Finger S, Wozniak D, Blumenthal H (1984) Longevity, disease, and autoimmune reactions following focal cortical injuries. In: Scheff SW (ed) Aging and recovery of function in the central nervous system. Plenum, New York, pp 1–21CrossRefGoogle Scholar
  24. Freund G, Walker DW (1971) The effect of aging on acquisition and retention of shuttle box avoidance in mice. Life Sci 10: 1343–1349CrossRefGoogle Scholar
  25. Gerbase-DeLima N, Liu RK, Cheney KE, Mickey R, Walford R (1975) Immune function and survival in a long-lived mouse strain subjected to undernutrition. Gerontologia 21: 184–202PubMedCrossRefGoogle Scholar
  26. Glenner GG (1978) Current knowledge of amyloid deposits as applied to senile plaques and congophilic angiopathy. In: Katzman R, Terry RD, Bick KL (eds) Alzheimer’s disease: Senile dementia and related disorders. Raven, New York, pp 493–501 (Aging, vol 7 )Google Scholar
  27. Harris CM, Forster MJ, Retz KC, Frantz N, Lal H (1984) Deficient retention of appetitive and aversive learning in New Zealand Black mice. Soc Neurosci Abs 10: 451Google Scholar
  28. Hijmans W, Radl J, Bottazzo GF, Doniach D (1984) Autoantibodies in highly aged humans. Mech Ageing Dev 26: 83–89PubMedCrossRefGoogle Scholar
  29. Hoffman SA, Hoffman AA, Shucard DW, Harbeck RJ (1978) Antibodies to dissociated cerebellar cells in New Zealand mice as demonstrated by immunofluorescence. Brain Res 142: 477–486PubMedCrossRefGoogle Scholar
  30. Hoffman SA, Arbogast DN, Day TT, Shucard DW, Harbeck RJ (1983) Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease. J Immunol 130: 1695–1698PubMedGoogle Scholar
  31. Howie JB, Helyer BJ (1968) The immunology and pathology of NZB mice. Adv Immunol 9: 215–223PubMedCrossRefGoogle Scholar
  32. Ingram CR, Phegan KJ, Blumenthal HT (1974) Significance of an aging-linked neuron binding gamma globulin fraction of human sera. J Gerontol 29: 20–27PubMedGoogle Scholar
  33. Ishii T, Haga S (1976) Immuno-electron microscopic localization of immunoglobulin in amyloid fibrils of senile plaques. Acta Neuropathol 36: 243–250PubMedCrossRefGoogle Scholar
  34. Ishii T, Haga S, Tajima M (1983) Viral antigens in senile plaques: an immunofluorescence study. In: Hirano A, Miyoshi K (eds) Neuropsychiatric disorders in the elderly. Igaku-Shoin, Tokyo, pp 32–38Google Scholar
  35. Johnson HA, Erner S (1972) Neuron survival in the aging mouse. Exp Gerontol 7: 111–117PubMedCrossRefGoogle Scholar
  36. Kobiler D, Fuchs S, Samuel D (1976) The effect of antisynaptosomal plasma membrane antibodies on memory. Brain Res 115: 129–138PubMedCrossRefGoogle Scholar
  37. Lal H, Carroll PT (1979) Alterations in brain neurotransmitter systems related to senescence. In: Nandy K (ed) Geriatric Psychopharmacology. Elsevier, New York, pp 3–15Google Scholar
  38. Lal H, Pogacar S, Daly P, Puri S (1973) Behavioral and neuropathological manifestations of nu- tritionally-induced central nervous system “aging” in the rat. Prog Brain Res 40: 129–140CrossRefGoogle Scholar
  39. Landfield PW (1983) Mechanisms of altered neural function during aging. In: Gispen WH, Traber J (eds) Aging of the brain. Elsevier, New York, pp 51–60 (Developments in neurology, vol 7 )Google Scholar
  40. MacPherson CFC, Chinerman J (1971) Effect of intraventricular injections of brain isoantibodies on learning. Exp Neurol 31: 45–52PubMedCrossRefGoogle Scholar
  41. Makinodan T (1976) Immunobiology of aging. J Am Geriatr Soc 24: 249–252PubMedGoogle Scholar
  42. Miller DT, Blumenthal HT (1978) Neuron-thymic lymphocyte binding by serum IgG of 90and 500 day old female Wistar albino rats. J Gerontol 33: 329–336PubMedGoogle Scholar
  43. Nagy ZM, Thaller K, Massaferri TA (1977) Acquisition and retention of a passive avoidance task as a function of age in mice. Dev Psychobiol 10: 563–573PubMedCrossRefGoogle Scholar
  44. Nandy K (1972a) Brain-reactive antibodies in mouse serum as a function of age. J Gerontol 27: 173–177PubMedGoogle Scholar
  45. Nandy K (1972b) Neuronal degeneration in aging and after experimental injury. Exp Gerontol 7: 303–311PubMedCrossRefGoogle Scholar
  46. Nandy K (1975) Significance of brain-reactive antibodies in serum of aged mice. J Gerontol 30: 412–416PubMedGoogle Scholar
  47. Nandy K (1977) Immune reactions in aging brain and senile dementia. In: Nandy K, Sherwin I (eds) The aging brain and senile dementia. Plenum, New York, pp 181–196 (Advances in behavioral biology, vol 23 )Google Scholar
  48. Nandy K (1978) Brain-reactive antibodies in aging and senile dementia. In: Katzman R, Terry R, Bick K (eds) Alzheimer’s disease-Senile dementia and related disorders. Raven, New York, pp 503–512Google Scholar
  49. Nandy K (1981a) Brain-reactive antibodies in aging non-human primates. Mech Ageing Dev 16: 141–146PubMedCrossRefGoogle Scholar
  50. Nandy K (1981b) Effects of caloric restriction on brain-reactive antibodies in sera of old mice. Age 4: 117–121CrossRefGoogle Scholar
  51. Nandy K (1981c) Senile dementia: a possible immune hypothesis. In: Mortimer JA, Shuman M (eds) Epidemiology of senile dementia. Oxford University Press, New York, pp 87–100Google Scholar
  52. Nandy K (1982) Effects of controlled dietary restriction on brain-reactive antibodies in sera of aging mice. Mech Ageing Dev 18: 97–102PubMedCrossRefGoogle Scholar
  53. Nandy K, Bennett M (1983) Immune manipulations and brain-reactive antibody formation in aging mice. Mech Ageing Dev 22: 287–293PubMedCrossRefGoogle Scholar
  54. Nandy K, Lal H, Bennett M, Bennett D (1983) Correlation between a learning disorder and elevated brain-reactive antibodies in aged C57BL/6 and young NZB mice. Life Sci 33: 1499–1503PubMedCrossRefGoogle Scholar
  55. Nandy K, Lal H, Bennett M, Bennett D (1984) Bone marrow transplant from aged to young mice produces brain reactive antibodies and concurrent acceleration of learning/memory deficits. Soc Neurosci Abs 10: 721Google Scholar
  56. Quimby FW, Schwartz RS (1982) Systemic lupus erythematosus in mice and dogs. In: Lachman PJ, Peters DK (eds) Clinical aspects of immunology, vol. 2. Blackwell, Oxford, pp 1217–1230Google Scholar
  57. Rappoport SL (1977) Reversible modification of blood-brain barrier permeability to proteins. In: Nandy K, Sherwin J (eds) The aging brain and senile dementia. Plenum, New York, pp 197–209 (Advances in behavioral biology, vol 3 )Google Scholar
  58. Rapport MM, Karpiak SE (1978) Immunological perturbation of neurological functions. In: Nandy K (ed) Senile dementia: A biomedical approach. Elsevier, New York, pp 73–88Google Scholar
  59. Ritger H (1983) Pitfalls in behavioral ageing research in animals. In: Gispen WH, Traber J (eds) Aging of the brain. Elsevier, New York, pp 197–208 (Developments in neurology, vol 7 )Google Scholar
  60. Schwartz AG, Nyce JW, Tannen RH (1984) Inhibition of tumorigenesis and autoimmune development in mice by dehydroepiandrosterone. In: Cristofalo VJ, Baker III GT, Andelman RC, Roberts J (eds) Altered endocrine status during aging. Liss, New YorkGoogle Scholar
  61. Scott DE, Sladek JR Jr (1981) Age-related changes in the endocrine hypothalamus: I. Tanycytes and the blood-brain cerebrospinal fluid barrier. Neurobiol Aging 2: 89–94PubMedCrossRefGoogle Scholar
  62. Severson JA, Finch CE (1980) Reduced dopaminergic binding during aging in the rodent striatum. Brain Res 192: 147–162PubMedCrossRefGoogle Scholar
  63. Simon J, Simon O (1975) Effect of passive transfer of antibrain antibodies to a normal recipient. Exp Neurol 47: 523PubMedCrossRefGoogle Scholar
  64. Spencer DG Jr, Lal H (1983) Specific behavioral impairments in associational tasks in mice with an autoimmune disorder. Soc Neurosci Abs 9: 1146Google Scholar
  65. Sprott RL (1980) An appraisal of the utility of genetic techniques for the study of neurobiology and aging in mice. In: Stein DG (ed) The psychobiology of aging: Problems and perspectives. Elsevier, New York, pp 21–33Google Scholar
  66. Threatt J, Nandy K, Fritz F (1971) Brain-reactive antibodies in serum of old mice demonstrated by immunofluorescence. J Gerontol 26: 316–323PubMedGoogle Scholar
  67. Vogel FS (1969) The brain and time. In: Busse EW, Pfeiffer E (eds) Behavior and adaptation in later life. Little Brown, Boston, pp 251–262Google Scholar
  68. Walker SE, Solsky M, Schnitzer B (1982) Prolonged lifespans in female NZB/NZW mice treated with the experimental immunoloreguatory drug Frentizole. Arthritis Rheum 25: 1291–1297PubMedCrossRefGoogle Scholar
  69. Weksler ME (1983) Senescence of the immune system. Med Clin North Am 67: 263–272PubMedGoogle Scholar
  70. Wisniewski HH, Koslowski (1982) Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). In: Sinex FM, Merrill CR (eds) Alzheimer’s disease, Down’s syndome, and aging. New York Academy of Sciences, New York, pp 119–129Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • H. Lal
    • 1
  • M. J. Forster
    • 1
  • K. Nandy
    • 2
    • 3
  1. 1.Department of PharmacologyTexas College of Osteopathic MedicineFort WorthUSA
  2. 2.Veterans Administration HospitalBedfordUSA
  3. 3.Department of AnatomyBoston University School of MedicineBostonUSA

Personalised recommendations